About TTY Biopharm
TTY Biopharm is a company based in Taipei (Taiwan) founded in 1960. TTY Biopharm operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Taipei, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tty Biopharm Company Limited
-
Annual Revenue
$5.9 B7.18as on Dec 31, 2024
-
Net Profit
$1.45 B28.45as on Dec 31, 2024
-
EBITDA
$1.6 B1.45as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of TTY Biopharm
TTY Biopharm is a publicly listed company on the TPEX with ticker symbol 4105 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of TTY Biopharm
Detailed funding history for TTY Biopharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TTY Biopharm
Investment portfolio details for TTY Biopharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TTY Biopharm
Detailed financials for TTY Biopharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tty Biopharm Comparisons
Peer comparison for TTY Biopharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TTY Biopharm
TTY Biopharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of TTY Biopharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tty Biopharm
Complete news archive for TTY Biopharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TTY Biopharm
TTY Biopharm was founded in 1960.
TTY Biopharm is headquartered in Taipei, Taiwan.
TTY Biopharm was founded in 1960 and is based in Taipei, Taiwan. Operations focus on the biopharmaceutical sector, with major technology platforms centered on liposome and microsphere systems. Conventional products encompass oral dosage forms such as immediate-release and sustained-release drugs, liquid injections, ointments, and gels. Services provided include formulation development, analytical development, process development, and animal studies.
TTY Biopharm's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Yes, TTY Biopharm is publicly traded on TPEX under the ticker symbol 4105.
The ticker symbol of TTY Biopharm is 4105 on TPEX.